This time next year, you may be swapping your GLP-1 injections for easier and as-effective oral weight-loss medication. It's ...

Semaglutide - the active ingredient in medications like Ozempic and WeGovy - is only FDA approved for Type-2 diabetes, but ...

Ozempic and other weight loss drugs could have a gnarly side effect dubbed “Ozempic-feet,” according to a report. The popular pound-shedding prescription drug is known to cause several ...

For all the hype surrounding weight loss injections, including Ozempic and Mounjaro, the elephant in the slimming room remains: what happens when you stop taking the injections? Wellness coach ...

Sign up for the best picks from our travel, fashion and lifestyle writers. But alongside the well-documented weight-loss effects, emerging scientific research has ...

Jr NTR's recent weight loss sparked rumors of Ozempic use, but his team clarified it's due to a strict diet and fitness regimen for his upcoming film. His past transformations, notably for RRR ...

Ozempic, initially for type 2 diabetes, has gained popularity for rapid weight loss, leading to a newly reported side effect dubbed "Ozempic feet." This condition results from the sudden loss of ...

Add articles to your saved list and come back to them any time. Pharmaceutical company Eli Lilly said its experimental pill worked as well as blockbuster drug Ozempic to lower weight and blood ...

Investing.com -- Shares of Eli Lilly and Company (NYSE:LLY) surged over 14% Thursday following the announcement of positive Phase 3 trial results ... photos, graphics, graphs, charts, animations and ...

A new daily tablet could be as effective as Ozempic for people with type 2 diabetes in lowering blood sugar and helping with weight loss, a trial has found. The drug, orforglipron, belongs to the ...

That outcome compares favorably to Novo Nordisk’s widely prescribed Ozempic, which helped diabetic ... jump by 15% on Thursday after unveiling positive results from a clinical trial of its ...

Eli Lilly stock surged as much as 17% after positive phase-three trial data came out for orforglipron. It found orforglipron, a GLP-1 weight-loss pill, led to significant weight and A1C reductions.